Microdeletion probes market is anticipated to grow at a significant CAGR during the forecast period. The growing research related to genomic DNA sequences coupled with the advancements in the biotechnology field has paved numerous opportunities for market growth. Microdeletions are considered to have a critical role in the occurrence, which results in the demand for the diagnosis of genetic disorders and cancer. These genetic diseases majorly include acute lymphoblastic leukaemia, Prader-Willi syndrome, Angelman syndrome, Down’s syndrome, chronic myelogenous leukaemia, Velocardiofacial syndrome, 22q13 deletion syndrome, and cri-du-chat. The rising incidences of these diseases are anticipated to create the demand for an effective diagnostic solution such as microdeletion probes. As per the Centers for Disease Control and Prevention (CDC) in 2018, Down’s syndrome was the most common genetic disorder with almost one in every 700 new newborns affected by the disorder.
These diseases can be diagnosed using microdeletion probes which can detect deletions or duplications in genomic DNA sequences. Microdeletion probes are primarily utilized for microarray studies, which enables the identification of genes in charge of human genetic disorders. These defects occur due to either missing or extra copy number regions in a specific region of a chromosome resulting in various diseases including cancers and autoimmune diseases. Microarray analysis provides information regarding gene expression pattern changes related to deletion or duplication of specific regions. Microdeletion probes are nucleic acid sequences ranging from 15 to 100 bases in length, which can detect deletions or duplications in genomic DNA sequences by acting as substrates for polymerase chain reaction (PCR) and fluorescence resonance energy transfer (FRET). Furthermore, some key players operating in the market include Abbott Laboratories, Creative Bioarray, Empire Genomics, and Leica Biosystems, among others.
To Request a Sample of our Report on Microdeletion Probes Market: https://www.omrglobal.com/request-sample/microdeletion-probes-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Abbott Laboratories, Creative Bioarray, Empire Genomics, and Leica Biosystems, among others.
Microdeletion Probes Market by Segment
By Type
- Dual Colour
- Multi-colour
By Application
- Cancer
- Autoimmune Diseases
- Others
A full Report of Microdeletion Probes Market is Available at: https://www.omrglobal.com/industry-reports/microdeletion-probes-market
Microdeletion Probes Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/microdeletion-probes-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404